Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Liu, Jiannan ^a,b   Xing, Yue ^c   Xu, Liqun ^a,b   Chen, Wantao ^a,b   Cao, Wei ^a,b   Zhang, Chenping ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Research Institute of Stomatology   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

ANIMAL; CELL MOTION; COPY NUMBER VARIATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; MOUSE; PSEUDOGENE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; DNA COPY NUMBER VARIATIONS; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; NEOPLASM INVASIVENESS; PSEUDOGENES; PTEN PHOSPHOHYDROLASE;

EID: 85010304506     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41179     Document Type: Article

References (32)

1. Chen, W., et al. Cancer statistics in China, 2015. CA: a cancer journal for clinicians 66, 115-132 (2016).
2. Cabanillas, R., et al. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer 109, 1791-1798 (2007).
3. Rinn, J. L., Chang, H. Y. Genome regulation by long noncoding RNAs. Annual review of biochemistry 81, 145-166 (2012).
4. Royce, T. E., et al. Issues in the analysis of oligonucleotide tiling microarrays for transcript mapping. Trends in genetics: TIG 21, 466-475 (2005).
5. Consortium, E. P., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816 (2007).
6. Pasmant, E., et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer research 67, 3963-3969 (2007).
7. Xu, G., et al. Small nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinoma. Molecular cancer 13, 216 (2014).
8. Orom, U. A., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 143, 46-58 (2010).
9. Liu, X. H., et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Molecular cancer 13, 92 (2014).
10. Batista, P. J., Chang, H. Y. Long noncoding RNAs: cellular address codes in development and disease. Cell 152, 1298-1307 (2013).
11. Ji, P., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041 (2003).
12. Tian, Y., Zhang, X., Hao, Y., Fang, Z., He, Y. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma research 24, 335-341 (2014).
13. Ren, S., et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. The Journal of urology 190, 2278-2287 (2013).
14. Zhou, S., Wang, J., Zhang, Z. An emerging understanding of long noncoding RNAs in kidney cancer. Journal of cancer research and clinical oncology 140, 1989-1995 (2014).
15. Gibb, E. A., et al. Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions. Oral oncology 47, 1055-1061 (2011).
16. Dahia, P. L., et al. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16, 2403-2406 (1998).
17. Fujii, G. H., Morimoto, A. M., Berson, A. E., Bolen, J. B. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN. Oncogene 18, 1765-1769 (1999).
18. Marsit, C. J., et al. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Human pathology 36, 768-776 (2005).
19. Poliseno, L., et al. Deletion of PTENP1 pseudogene in human melanoma. The Journal of investigative dermatology 131, 2497-2500 (2011).
20. Poliseno, L., et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033-1038 (2010).
21. Zhou, Y., Zhang, X., Klibanski, A. MEG3 noncoding RNA: a tumor suppressor. Journal of molecular endocrinology 48, R45-53 (2012).
22. Fang, Z., et al. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral surgery, oral medicine, oral pathology and oral radiology 117, 89-95 (2014).
23. Tang, H., Wu, Z., Zhang, J., Su, B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Molecular medicine reports 7, 761-766 (2013).
24. Ulger, C., et al. Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line. Cancer genetics and cytogenetics 147, 28-35 (2003).
25. Wang, C. C., et al. [Study on expression of PTEN gene and its pseudogene PTENP1 in acute leukemia and correlation between them]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 33, 896-901 (2012).
26. Li, G., et al. Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing. PloS one 8, e84486 (2013).
27. Yu, G., et al. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Molecular cancer therapeutics 13, 3086-3097 (2014).
28. Ioffe, Y. J., Chiappinelli, K. B., Mutch, D. G., Zighelboim, I., Goodfellow, P. J. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis? Gynecologic oncology 124, 340-346 (2012).
29. Hesson, L. B., et al. A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines. Biological procedures online 14, 5 (2012).
30. Leslie, N. R., den Hertog, J. Mutant PTEN in Cancer: Worse Than Nothing. Cell 157, 527-529 (2014).
31. Papa, A., et al. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 157, 595-610 (2014).
32. Chen, C. L., et al. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation. Biomaterials 44, 71-81 (2015).